🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Medi-Caps Limited MEDICAPQ NSE

Real Estate · Real Estate - Diversified · India
https://www.medicaps.com
Company Profile ↓
₹26.29
+4.95% 1Y
Mkt Cap₹32.78 Cr
P/E-10.77
P/B0.28
52W High₹26.99
52W Low₹23.56
Book Value₹89.50
EPS (TTM)₹-2.44

Company Overview

Medi-Caps Limited engages in the real estate business in India. The company was incorporated in 1983 and is based in Indore, India.

Why Investors Should Care

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.00.

Recent Developments

  • Mar 2026 Revenue of ₹12.40 Cr (-51.1% YoY); net profit ₹-3.04 Cr.
  • Trailing 12 Months Year-on-year growth — revenue -51.1%.
  • 5-Year Trend Long-term compounding — revenue CAGR -36.6%, profit CAGR -91.0%.

Growth & Price Performance

Compounded Sales Growth

5 Years:-36.57%
1 Year:-51.15%

Compounded Profit Growth

5 Years:-91.00%
1 Year:-

Stock Price Performance

1 Year:+4.95%
6 Months:-
3 Months:-
1 Month:-

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot
52-Week Range 80% of range
₹23.56 ₹26.99
Price Performance
1Y+4.95%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Revenue declined at -36.6% CAGR over 5 years.
  • Earnings shrank at -91.0% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-10.77
Industry PE
26.19
Forward P/E
-
PEG Ratio
-
Book Value
₹89.50
Price to Book
0.28
P/S
2.54
EV/EBITDA
-0.97
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-36.57%
Profit 5Y
-91.00%
Revenue (YoY)
-51.15%
Earnings (YoY)
-

Profitability & Returns

ROCE
-9.95%
ROE
-2.72%
ROA
-2.63%
Profit Margin
-24.50%
Op Margin
-90.51%
Gross Margin
54.50%
EPS (Latest Qtr)
₹-
EPS (TTM)
₹-2.44

Balance Sheet & Liquidity

Debt/Equity
0.00
Quick Ratio
16.26
Current Ratio
17.34
Debt
₹0
Total Assets
₹115.46 Cr
Current Assets
₹47.02 Cr
Working Capital
₹44.31 Cr

Ownership

Promoter Holding
64.89%
Chg in Prom Hold
-
FII / Inst Holding
0.00%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
₹32.78 Cr
Total Revenue (TTM)
₹12.40 Cr
EBITDA
₹-1.20 Cr
Free Cash Flow
₹-7.87 Cr
Operating Cash Flow
₹-7.02 Cr
Shares Outstanding
₹1.25 Cr
Gross Margin
54.50%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Real Estate).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 MEDICAPQ Medi-Caps Limited NSE 26.29 -10.77 ₹32.78 Cr 0.00% -9.95% -2.72% -36.57% -91.00%
2 DLF DLF Limited NSE 681.90 38.24 ₹1.69 L Cr 1.25% 6.32% 9.71% 11.32% 29.44%
3 LODHA Lodha Developers Limited NSE 1,222.00 35.68 ₹1.22 L Cr 0.35% 18.24% 14.72% 20.40% 91.69%
4 PHOENIXLTD The Phoenix Mills Limited NIFTY_MIDNSE 1,942.00 55.45 ₹69,452.65 Cr 0.13% 11.84% 11.14% 19.36% -2.86%
5 PRESTIGE Prestige Estates Projects Limited NIFTY_MIDNSE 1,587.00 57.17 ₹68,356.89 Cr 0.13% 12.48% 7.35% 15.15% 8.28%
6 OBEROIRLTY Oberoi Realty Limited NIFTY_MIDNSE 1,875.60 27.20 ₹68,197.24 Cr 0.45% 16.71% 13.99% 12.92% 9.60%
7 GODREJPROP Godrej Properties Limited NIFTY_MIDNSE 1,982.00 32.27 ₹59,699.37 Cr 0.48% 11.14% 9.66% 32.38% 47.94%
8 BRIGADE Brigade Enterprises Limited NIFTY_SMALLNSE 696.10 35.25 ₹22,701.53 Cr 0.35% 9.78% 9.45% 18.55% 30.28%
9 ANANTRAJ Anant Raj Limited NIFTY_SMALLNSE 625.45 39.56 ₹22,508.50 Cr 0.16% 10.39% 9.62% 37.94% 54.47%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 6.94 Cr2.68 Cr2.01 Cr4.29 Cr3.42 Cr
Cost of Revenue 2.78 Cr1.59 Cr61.10 L1.90 Cr1.54 Cr
Gross Profit 4.16 Cr1.09 Cr1.39 Cr2.39 Cr1.88 Cr
Operating Expenses 4.82 Cr4.90 Cr4.74 Cr3.89 Cr4.44 Cr
Operating Income -66.53 L-3.81 Cr-3.35 Cr-1.50 Cr-2.56 Cr
EBITDA 1.91 Cr-3.04 Cr-1.38 Cr-30.05 L3.53 Cr
Interest Expense 2.48 L1.30 L000
Pretax Income 1.45 Cr-3.49 Cr-1.82 Cr-73.73 L3.03 Cr
Tax Provision -27.01 L002.85 L-1.44 L
Net Income 1.72 Cr-3.49 Cr-1.82 Cr-76.58 L3.04 Cr
Diluted EPS -----

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue -48.58 Cr26.56 Cr25.37 Cr12.40 Cr
Cost of Revenue -25.11 Cr9.52 Cr10.65 Cr5.64 Cr
Gross Profit -23.47 Cr17.05 Cr14.72 Cr6.76 Cr
Operating Expenses -20.65 Cr18.77 Cr18.27 Cr17.98 Cr
Operating Income -2.81 Cr-1.72 Cr-3.55 Cr-11.22 Cr
EBITDA -6.73 Cr44.05 L90.19 L-1.20 Cr
Interest Expense -16,00002.48 L1.30 L
Pretax Income -4.92 Cr-1.25 Cr-84.11 L-3.02 Cr
Tax Provision -3.05 Cr99.47 L-27.01 L1.41 L
Net Income -1.76 Cr-2.24 Cr-57.10 L-3.04 Cr
Diluted EPS -1.41-1.80-0.46-2.44

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -125.99 Cr127.28 Cr125.42 Cr115.46 Cr
Current Assets -60.20 Cr60.01 Cr53.44 Cr47.02 Cr
Cash & Equivalents -1.11 Cr32.14 L41.20 L50.31 L
Inventory -7.07 Cr5.74 Cr3.20 Cr2.94 Cr
Receivables -8.46 Cr10.82 Cr8.79 Cr6.92 Cr
Total Liabilities -7.42 Cr6.30 Cr4.15 Cr3.85 Cr
Current Liabilities -6.39 Cr5.26 Cr3.10 Cr2.71 Cr
Long Term Debt -----
Total Debt -0000
Total Equity -118.57 Cr120.98 Cr121.28 Cr111.61 Cr
Shares Outstanding -1.25 Cr1.25 Cr1.25 Cr1.25 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow --6.08 Cr6.94 Cr5.07 Cr-7.02 Cr
Investing Cash Flow --2.56 Cr-7.73 Cr-4.98 Cr7.11 Cr
Financing Cash Flow -0000
Capital Expenditure --1.16 Cr-34.58 L-32.59 L-84.64 L
Free Cash Flow --7.24 Cr6.59 Cr4.74 Cr-7.87 Cr
Net Change in Cash --8.64 Cr-79.21 L9.06 L9.11 L

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -48.3%64.2%58.0%54.5%
Operating Margin % -5.8%-6.5%-14.0%-90.5%
Net Margin % -3.6%-8.4%-2.3%-24.5%
ROE % -1.5%-1.9%-0.5%-2.7%
ROCE % -2.4%-1.4%-2.9%-10.0%

Shareholding Pattern

Insiders
64.89%
Institutions
0.00%
Public Float
0.00%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for MEDICAPQ

Google News ue, 18 Aug 2026

MEDICAPQ Stock Price and Chart — NSE:MEDICAPQ - TradingView

<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE9HeTdnZE5ZYTZtUloxOGFKVlJ5NVZIZGszelFEdGpQem9XN1QyZFlQS2VVMDVQZGF0WVhRRzNfcGJ0cnJ6RDk3T2UtaWNvYnVzSXI4MzhPZzFoQ18tbnc?oc=5" target="_blank">MEDICAPQ Stock Price and Chart — NSE:MED…

Google News Wed, 19 Aug 2026

Medi-Caps Ltd. (MEDICAPQ) Profile, Company FAQs & Facts, Industry, Sector, Employee Strength - Stocktwits

<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE1kVHdQajZrRko5bmhPY2VhSkh0b0swZ1N4TmNoSThSX0tVejFfM181dzRMZjZlT3ExaGpVTkVtUS0xcldBZGQ4UVZTaEF5eHZuNm5tMTY4c1FWc0Ro?oc=5" target="_blank">Medi-Caps Ltd. (MEDICAPQ) Profile, Company …

Google News Wed, 19 Aug 2026

Medi-Caps Ltd. (MEDICAPQ) Share Price Today, Quote, Latest Discussions, Interactive Chart and News - Stocktwits

<a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE5ydjBnV3diV1Z0RXR4RXVoajl0XzlvcVYzRVhRcExUMzFfSFVlMGowQzJSSGEzVFVVM3lRVVQ1ek5ua3QtTFV6bHUwZzEyM0YwTlBCeg?oc=5" target="_blank">Medi-Caps Ltd. (MEDICAPQ) Share Price Today, Quote, L…

Google News Wed, 19 Aug 2026

MEDICAPQ Historical Data - equitypandit.com

<a href="https://news.google.com/rss/articles/CBMiY0FVX3lxTFB2dU53cDEzdi1jU0lKVkZGU2FiYnpGWnVWVVg0R19OSW1mQWVMUlJHUFFNZzRxSGxWZWRZcjRuaXFTOGh2QUJXRHJPYTZxRnI3TlcyT2RlRnJBZUhsZzZ3b2pMbw?oc=5" target="_blank">MEDICAPQ Historical Data</a>&nbsp…

Google News Wed, 19 Aug 2026

Medi-Caps Ltd. (MEDICAPQ) sentiment score, message volume, participation score and buzz level - Stocktwits

<a href="https://news.google.com/rss/articles/CBMiYkFVX3lxTE5SOEJSOHc0SWJVYlZWc0pMcjRET19ZZnBWUmZlTmFtVFJoSEJXbi02Rk1STmlGRGtzTzUybG5vYUFYZUNicWtGaUo0MmNxTnpxbWg0NkpNMVFYbVc4NWNvdHhn?oc=5" target="_blank">Medi-Caps Ltd. (MEDICAPQ) sentiment…

Google News Mon, 04 Aug 2025

MediCaps Ltd. Share Price Today - MediCaps Ltd. Stock Price Live NSE/BSE - CNBC TV18

<a href="https://news.google.com/rss/articles/CBMie0FVX3lxTE1PTjlzLTBvU0M0NFMtTy1fMkFiWDhHQnU3a0tIbm9YYXVIb0tQUUpOSm1PU2k3N2pGdFpuTTBBYWNRdTdXR0NNOFlQdEplUDBwTDBEeVIwME13M2hPRFIxeVRDbS0wYl95U1F5c2piQ2NQbnNnTTczNEhpSQ?oc=5" target="_blank">M…

MEDICAPQ — Frequently Asked Questions

What is the current share price of Medi-Caps Limited (MEDICAPQ)?

As of 2026-09-08 04:53 IST, Medi-Caps Limited (MEDICAPQ) trades at ₹26.29 on NSE. Its 52-week range is ₹23.56 to ₹26.99.

What is the market capitalisation of MEDICAPQ?

Medi-Caps Limited (MEDICAPQ) has a market capitalisation of ₹32.78 Cr on NSE.

What is the P/E ratio of MEDICAPQ?

MEDICAPQ trades at a trailing price-to-earnings (P/E) ratio of -10.77. The industry average P/E is 26.19. Its price-to-book (P/B) ratio is 0.28.

What is the return on equity (ROE) of MEDICAPQ?

MEDICAPQ has a return on equity (ROE) of -2.72%. Its return on capital employed (ROCE) is -9.95%.

Is MEDICAPQ a good stock to buy?

This page provides a data-driven analysis of Medi-Caps Limited (MEDICAPQ), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Real Estate Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space